Jan 29, 2026

  • Corporate

Personnel Changes

TOKYO, January 29, 2026 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes, effective March 26 and April 1, 2026, respectively.

[Details of Personnel Changes]
Effective March 26, 2026

Director

NameNew ResponsibilitiesCurrent Responsibilities
Kinuko Mitani Director -
  • The appointment of Kinuko Mitani as Director is subject to approval at the 115th Annual General Meeting of Shareholders, which is scheduled to be convened on March 26, 2026.
  • Mariko Y Momoi is scheduled to retire from Director as of March 26, 2026.

Effective April 1, 2026

Executive Officer

NameNew ResponsibilitiesCurrent Responsibilities
Kazuhiko Nishi Vice President
Head of Medical Affairs Div.
Associate Vice President
Head of Medical Affairs Div.

Associate Vice Presidents

NameNew ResponsibilitiesCurrent Responsibilities
Norihiro Awaya Associate Vice President
Deputy Head of Translational Research Div.
Deputy Head of Translational Research Div.
Junichi Takano Associate Vice President
Head of Marketing & Sales Div.
Head of Marketing & Sales Div.
Kenji Kamada Associate Vice President
President of Chugai Pharma Manufacturing Co., Ltd
President of Chugai Pharma Manufacturing Co., Ltd
Yumiko Asano Associate Vice President
Head of Partnering Dept.
Head of Partnering Dept.
Takehisa Kitazawa Associate Vice President
Deputy Head of Research Div., and Head of Discovery Pharmacology 2 Dept.
Deputy Head of Research Div., and Head of Discovery Pharmacology 2 Dept.

Contact:

  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Naoki Kouzai
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Takayuki Sakurai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp